PlainRecalls
FDA Devices Moderate Class II Ongoing

HemosIL ReadiPlasTin, Part No. 0020301400

Reported: May 18, 2022 Initiated: April 8, 2022 #Z-1052-2022

Product Description

HemosIL ReadiPlasTin, Part No. 0020301400

Reason for Recall

Variable and out of specification QC results with HemosIL ReadiPlasTin. IL will remove all lots from the market and convert customers to an alternative prothrombin time (PT) reagent, specifically HemosIL RecombiPlasTin 2G.

Details

Units Affected
1,563 (US); 29,046 (OUS)
Distribution
US Nationwide distribution including in the states of AZ, CA, IA, IL, IN, KS, MD, ME, MI, MN, MO, NC, NE, NY, OH, OK, SC, TX, VA, WV.
Location
Bedford, MA

Frequently Asked Questions

What product was recalled?
HemosIL ReadiPlasTin, Part No. 0020301400. Recalled by Instrumentation Laboratory. Units affected: 1,563 (US); 29,046 (OUS).
Why was this product recalled?
Variable and out of specification QC results with HemosIL ReadiPlasTin. IL will remove all lots from the market and convert customers to an alternative prothrombin time (PT) reagent, specifically HemosIL RecombiPlasTin 2G.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 18, 2022. Severity: Moderate. Recall number: Z-1052-2022.